EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Management of fracture risk in CKD—traditional and novel approaches

Mathias Haarhaus, Louise Aaltonen iD, Daniel Cejka, Mario Cozzolino iD, Renate T de Jong, Patrick D'Haese, Pieter Evenepoel iD, Marie-Hélène Lafage-Proust, Sandro Mazzaferro iD, Eugene McCloskey, Syazrah Salam iD, Hanne Skou Jørgensen iD und 1 weitere

Clinical Kidney Journal · 28.02.2023 · 16 (3) · 456-472

DOI: 10.1093/ckj/sfac230 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Kidney Journal, online erschienen am 22.10.2022. Verfasst von Mathias Haarhaus und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital, Karolinska Institutet, Stock…. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coexistence of osteoporosis and chronic kidney disease (CKD) is an evolving healthcare challenge in the face of increasingly aging populations. Globally, accelerating fracture incidence causes disability, impaired quality of life and increased mortality. Consequently, several novel diagnostic and therapeutic tools have been introduced for treatment and prevention of fragility fractures. Despite an especially high fracture risk in CKD, these patients are commonly excluded from interventional trials and clinical guidelines. While management of fracture risk in CKD has been discussed in recent opinion-based reviews and consensus papers in the nephrology literature, many patients with CKD stages 3–5D and osteoporosis are still underdiagnosed and untreated. The current review addresses this potential treatment nihilism by discussing established and novel approaches to diagnosis and prevention of fracture risk in patients with CKD stages 3–5D. Skeletal disorders are common in CKD. A wide variety of underlying pathophysiological processes have been identified, including premature aging, chronic wasting, and disturbances in vitamin D and mineral metabolism, which may impact bone fragility beyond established osteoporosis. We discuss current and emerging concepts of CKD–mineral and bone disorders (CKD-MBD) and integrate management of osteoporosis in CKD with current recommendations for management of CKD-MBD. While many diagnostic and therapeutic approaches to osteoporosis can be applied to patients with CKD, some limitations and caveats need to be considered. Consequently, clinical trials are needed that specifically study fracture prevention strategies in patients with CKD stages 3–5D.

Schlagwörter

Stichwörter der Autor:innen

biomarkersbone mineral densityfracture riskmineral metabolismrenal osteodystrophy

Autor:innen und Institutionen

  • Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Diaverum Sweden, Malmö, Sweden.
  • Turku University Hospital, Kidney Center, Department of Medicine, Turku, Finland.
  • Department of Medicine III - Nephrology, Hypertension, Transplantation, Rheumatology, Geriatrics, Ordensklinikum Linz - Elisabethinen Hospital, Linz, Austria.
  • Department of Health Sciences, Renal Division, University of Milan, ASST Santi Paolo e Carlo, Milan, Italy.
  • Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Internal Medicine and Endocrinology, Amsterdam, The Netherlands.

ORCID-Profile: Louise Aaltonen, Mario Cozzolino, Pieter Evenepoel, Sandro Mazzaferro, Syazrah Salam, Hanne Skou Jørgensen, Marc Vervloet

Förderung

  • Medical Research Council

Zitieren

APA

Haarhaus, M., Aaltonen, L., Cejka, D., Cozzolino, M., de Jong, R. T., D'Haese, P., Evenepoel, P., Lafage-Proust, M. H., Mazzaferro, S., McCloskey, E., Salam, S., Skou Jørgensen, H., & Vervloet, M. (2023). Management of fracture risk in CKD—traditional and novel approaches. Clinical Kidney Journal, 16(3), 456-472. https://doi.org/10.1093/ckj/sfac230

Vancouver

Haarhaus M, Aaltonen L, Cejka D, Cozzolino M, de Jong RT, D'Haese P, et al. Management of fracture risk in CKD—traditional and novel approaches. Clinical Kidney Journal. 2023;16(3):456-472. doi:10.1093/ckj/sfac230

BibTeX
@article{Haarhaus2023,
  author = {Haarhaus, Mathias and Aaltonen, Louise and Cejka, Daniel and Cozzolino, Mario and de Jong, Renate T and D'Haese, Patrick and Evenepoel, Pieter and Lafage-Proust, Marie-Hélène and Mazzaferro, Sandro and McCloskey, Eugene and Salam, Syazrah and Skou Jørgensen, Hanne and Vervloet, Marc},
  title = {Management of fracture risk in CKD—traditional and novel approaches},
  journal = {Clinical Kidney Journal},
  year = {2023},
  volume = {16},
  number = {3},
  pages = {456--472},
  doi = {10.1093/ckj/sfac230}
}
Kostenlos starten →